Ebix today announced the appointment of Mary Beth Titsworth as Vice President, Health Content, for its Health and Wellness vertical. In this role, Titsworth will lead the growth strategy for Oakstone and A.D.A.M. Oakstone has provided continuing medical education for physicians and clinicians for 50 years. A.D.A.M. has delivered evidence-based health information and interactive medical content for more than 25 years. Together, the two brands give Ebix a strong foundation in trusted medical education, clinical content, and health engagement.
Titsworth will lead content strategy, product direction, go-to-market execution, and commercial expansion across healthcare providers, health systems, academic institutions, payers, and B2B partners.
The appointment comes as Ebix continues to invest in the next phase of its Health and Wellness vertical. Physician-led content quality remains the foundation of Oakstone and A.D.A.M., while new technology, automation, and AI-assisted tools are being used to improve content development, delivery, personalization, and operating efficiency. The strategy also includes new ways for clinicians to engage with CME, including launch of CMEescape, a new concept that pairs accredited medical education with curated travel experiences.
“Oakstone and A.D.A.M. are trusted brands for clinical content and healthcare education,” said Gagan Sethi, Chief Executive Officer of Ebix Technologies. “That is a very strong foundation to build from. Mary Beth brings the commercial experience, healthcare market understanding, and execution focus needed to help us expand these assets into new revenue opportunities. Our goal is to preserve the clinical rigor behind these brands while using AI and automation to improve our operating model.”
“Clinicians and healthcare organizations have trusted Oakstone and A.D.A.M. for decades because the content is credible and built with care,” said Titsworth. “My focus will be to protect that foundation while expanding how we serve providers, healthcare organizations, partners, and patients through stronger strategic partnerships. I am excited to help shape the next chapter of these brands at Ebix.”
Read Also: IntelliGenome Appoints ILEX South Africa as Exclusive Distributor for CRISPR-TB
